Osteoneurogen
Seoul
About Osteoneurogen
Osteoneurogen specializes in anti-IPF and senotherapeutics. The company develops fibrosis and autoimmune disease treatments based on plant-based pharmacological compounds known as chromone scaffold compounds.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Series Unknown (Jan 2015)
- Website: osteoneurogen.com
- Phone: 02-6267-2738
Industries & Categories
Biotechnology, Life Science, Therapeutics
Canonical: https://fsome.com/organization/osteoneurogen-2746358 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.